EFPIA Newsletter 14 September 2023

News     13 September 2023 SOTEU 2023: Reconciling policy and practice Our hope now is that we can work with all parties to make the legislation enhance rather than hinder European competitiveness... Read more →         12 September 2023 Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body... How can we ensure that oncology-relevant endpoints reflect the value of innovation for patients, clinicians, payers... Read more →         12 September 2023 EFPIA working with Ukraine on EU accession and medicines and vaccines regulatory alignment... Representatives from the European Federation of Pharmaceutical Industries and Associations (EFPIA) today met in Brussels... Read more →

Did you miss our latest event? Watch the recording!

	Unlocking the potential of new oncology treatments. A cross-stakeholder discussion on improving the understanding, acceptance and use of oncology-relevant endpoints in reimbursement decision-making at the absence of OS.

Events     26 SEP 2023   Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection... Online Moving towards a new Alzheimer’s disease detection and diagnosis pathway Learn more →       29 SEP 2023   Are medicines affordable for health systems? Bad Hofgastein, Austria The myths, the facts, and the way forward Learn more →

	16 OCT 2023			33rd Alzheimer Europe Conference Helsinki, Finland, & virtual New opportunities in dementia care, policy and research Learn more →

	17 OCT 2023			EFGCP Better Medicines for Children Conference 2023 Amsterdam Global Paediatric Drug Development: the value of multi-stakeholders’ collaboration Learn more →

Publications Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body / payer decision-making.   Read EFPIA's latest White Paper.

What we are reading Lars Fruergaard Jørgensen, the Novo Nordisk boss who dethroned Europe’s biggest company 08 September 2023  (Financial Times) Read more → New AI tool makes it possible to predict weight loss after bariatric surgery 30 August 2023  (University College Dublin) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe